Ventyx Biosciences Inc expected to post a loss of 47 cents a share - Earnings Preview

Ventyx Biosciences

30/07/2025 21:07

Ventyx Biosciences Inc VTYX.OQ VTYX.O is expected to  show no change in quarterly revenue when it reports  results on August 1 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Ventyx Biosciences Inc is for a loss of 47 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Ventyx Biosciences Inc is $12.50, about 78.6% above its last closing price of $2.67

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.49
-0.48
-0.39
Beat
19.5
Dec. 31 2025
-0.55
-0.54
-0.41
Beat
24.2
Sep. 30 2024
-0.50
-0.52
-0.50
Beat
3.4​
Jun. 30 2024
-0.57
-0.58
-0.45
Beat
22.2
​​Mar. 31 2024
-0.68
-0.69
-0.62
Beat
9.7
Dec. 31 2023
-0.91
-0.90
-0.79
Beat
12.5​
Sep. 30 2023
-0.89
-0.90
-0.92
Missed
-2.7
Jun. 30 2023
-0.72
-0.71
-0.91
Missed
-28

This summary was machine generated July 30 at 20:07 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)